[PLX] YoY Quarter Result on 31-Dec-2005 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
30-Mar-2006
Financial Year
2005
Quarter
31-Dec-2005 [#Q4]
Profit Trend
QoQ- 37.50%
YoY- 37.50%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
Revenue 1,176 388 0 0 150 0 0 -
PBT 22,414 31,440 9,390 -2,080 5,717 0 0 -
Tax -20,470 -16,504 -15,838 -20,800 -118 20 32 -
NP -8,528 -14,936 -6,576 -5,131 -9,301 -20 -32 153.57%
Tax Rate 91.33% 52.49% 168.67% - 2.06% - - -
Total Cost 9,704 15,324 6,576 5,131 9,451 20 32 159.08%
Ratio Analysis
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
NP Margin -725.17 -3,849.48 0.00 0.00 -6,200.63 0.00 0.00 -
Per Share
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
EPS -1.04 -1.85 -0.87 -0.70 -1.45 -0.34 -1.08 -0.62%
EPS Diluted -1.04 -1.85 -0.87 -0.68 -1.45 -0.34 -1.08 -0.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.